75 results
8-K
EX-99.1
8cuj l1v6pp7
11 Oct 22
Nephros Announces Agreement to Sell Pathogen Detection Systems Business and Active Customer Sites Increase 18% YoY
7:30am
8-K
EX-10.1
t49fvl
13 Oct 20
Entry into a Material Definitive Agreement
4:15pm
8-K
vfx x2cz4acm99huufby
13 Oct 20
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-99.1
9swp80jznf 4k
14 Aug 20
Nephros Names Andy Astor President and Chief Executive Officer
4:15pm
8-K
EX-99.1
9jquzxravmgiv msj6kg
31 Jan 20
Nephros Announces Pricing of $7.5 Million Underwritten Offering of Common Stock
10:44am
8-K
ijl6o8x10
31 Jan 20
Nephros Announces Pricing of $7.5 Million Underwritten Offering of Common Stock
10:44am
8-K
EX-10.1
o3nmn2sa
26 Dec 19
Entry into a Material Definitive Agreement
8:00am
8-K
EX-99.1
z3peqrx 3og7j
13 Aug 19
Nephros Announces Listing on Nasdaq Capital Market
7:45am
424B3
1crj9uredi21r5pz
25 Jun 18
Prospectus supplement
7:01am